Orale Vitamin-B12-Substitution bei funikulrer Myelose
(9) While it has never been shown in a dedicated trial, a recent network meta-analysis [44] suggested that GLP-1 RAs may reduce the risk for ESKD (HR 0.78
Davies said several GLP-1/glucagon dual agonists have moved on to phase 2 or phase 3 trials, including survodutide (Boehringer Ingelheim), efinopegdutide (Hanmi Pharmaceutical), mazdutide (Eli Lilly and Innovent) and pemvidutide (Altimmune)
We used the search terms fracture, osteoporosis, semaglutide, calorie restriction, bariatric surgery, bone density, bone turnover markers, liraglutide, tirzepatide, Glucagon-like peptide 1, and glucagon-like peptide receptor analogues in combination with the terms obesity and diabetes
Mehta LS, Velarde GP, Lewey J, Sharma G, Bond RM, Navas-Acien A, et al